Company News in the Life Science Industry

»

Reset 

Todos Medical CEO Releases Letter to Shareholders

Read more ››
By: GlobenewsWire - 18 Sep 2020
Related companies:  Todos Medical Ltd.

Medexus Engages Adelaide Capital for Investor Relations Services and Reports Annual Meeting Results

Read more ››
By: GlobenewsWire - 18 Sep 2020
Related companies:  Medexus Pharmaceuticals Inc.

Coherus BioSciences Announces New Employment Inducement Grants

Read more ››
By: GlobenewsWire - 18 Sep 2020
Related companies:  Coherus BioSciences, Inc.

Nanox to Participate in the Oppenheimer’s Virtual Fall Healthcare Life Sciences & MedTech Summit

Read more ››
By: GlobenewsWire - 18 Sep 2020
Related companies:  Nanox Imaging Ltd.

Orfadin® (nitisinone) receives positive opinion from CHMP for treatment of AKU

STOCKHOLM, Sept. 18, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) today announces that the Committee... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020
Related companies:  Swedish Orphan Biovitrum AB (Sobi™) | Sobi

BrainCool Announces Statistically Significant Late-Breaking Clinical Data at ESMO Virtual Congress 2020

LUND, Sweden, Sept. 18, 2020 /PRNewswire/ -- BrainCool AB, a Swedish medical device innovator, and a world leader... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020
Related companies:  BrainCool AB

Alkermes Presents New Clinical Data on ALKS 4230 in Mini Oral Presentation at 2020 European Society for Medical Oncology (ESMO) Virtual Congress

DUBLIN, Sept. 18, 2020 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented new clinical data from ARTISTRY-1, an ongoing phase... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020

AKL Research & Development's novel osteoarthritis medicine APPA begins Phase II trial with partner Nordic Bioscience Clinical Development

STEVENAGE, England and COPENHAGEN, Denmark, Sept. 18, 2020 /PRNewswire/ -- A novel, oral osteoarthritis (OA) medicine being developed by AKL Research and Development (AKLRD) has recruited its first patient into its Phase II human clinical trial being conducted by its partner Nordic Bioscience... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020

Foundation for the NIH Awards 2020 Trailblazer Prize for Clinician-Scientists to Michael Wilson, M.D.

NORTH BETHESDA, Md., Sept. 18, 2020 /PRNewswire/ -- The Foundation for the National Institutes of Health (FNIH) today bestowed its annual Trailblazer Prize for Clinician-Scientists to Michael Wilson, M.D., of the University of California San Francisco (UCSF). Dr. Wilson has received... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020
Related companies:  Foundation for the National Institutes of Health

Achieve Announces Presentation of Investigator-Led RAUORA Trial Data Demonstrating Significantly Fewer Side Effects with Higher Quit Rates for Cytisinicline (cytisine) Compared to Chantix® (varenicline) in First Head-to-Head Comparative Study

SEATTLE and VANCOUVER, BC, Sept. 18, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today announced presentation of... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020
Related companies:  Achieve Life Sciences, Inc.

Global Contract Research Organization (CRO) Markets, 2019-2020 & 2024: Increased Adoption of Hybrid Clinical Trials and Remote Patient Monitoring

DUBLIN, Sept. 18, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020

AIkido Pharma Announces Update On Its Use Of Artificial Intelligence

NEW YORK, Sept. 18, 2020 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) today announced that its work with research partner, Cogia BioTech LTD (www.cogia.de), has delivered several key updates on efforts to accelerate the study of PDA (Pancreatic Ductal... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020
Related companies:  AIkido Pharma Inc.

Japan Cancer Oncology Drug Therapeutics Market Sales Size Offers US$ 15 Billion Opportunity With 1600 Drug In Clinical Trials

Kuick Research Report Given Comprehensive Insight On All Clinical & Commercial Aspects Related To Japan Cancer Drug Market

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2020

In-Vitro Diagnostics (IVDs) Market to reach US$ 98 Billion by 2025, Globally |CAGR: 5.24%|UnivDatos Market Insights

NOIDA, India, Sept. 18, 2020 /PRNewswire/ -- UnivDatos Market Insights released a report titled "In-Vitro Diagnostics Market by Product (Reagents and Instruments Services),... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020

Global Antibiotics Markets, 2015-2019 & 2020-2030 with 2019 as the Base Year

DUBLIN, Sept. 18, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020

Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Two Lots of NP Thyroid®, Thyroid Tablets, USP Due to Sub Potency

ATLANTA, Sept. 18, 2020 /PRNewswire/ -- Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid(®), Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because testing has found... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020

Prefilled Syringes Market worth $8.6 billion by 2025 - Exclusive Report by MarketsandMarkets™

CHICAGO, Sept. 18, 2020 /PRNewswire/ -- According to the new market research report "Prefilled Syringes... Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020

United States Medical Masks Market 2019-2020 & 2025: Largest Manufacturers are 3M, Honeywell, Kimberly-Clark, Owens & Minor, and Prestige Ameritech

DUBLIN, Sept. 18, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020

North America Liquid Biopsy Market Report 2020 Featuring Major Players - Exosome Diagnostics, Thermo Fisher Scientific and Bio-Rad Laboratories

DUBLIN, Sept. 18, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 18 Sep 2020

Experimental Drug Blocks COVID-19 Viral Entry into Lung Cells

NEW YORK, Sept. 18, 2020 /PRNewswire/ -- An experimental compound prevents the virus that causes COVID-19 from entering human airway cells, a new study finds.

Read more ››
By: PR Newswire Association LLC. - 18 Sep 2020
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies